FDA Approves Cannabidiol for Use in Epilepsy
Node Smith, ND On April 19, 2018, an advisory panel from the Federal Food and Drug Administration (FDA) recommended a new drug to be approved for the treatment of epilepsy.1 The drug, Epidiolex, produced by GW Pharmaceuticals in Britain, is a pure oral solution of cannabidiol, one of the primary endocannabinoids found in the herb […]
Study Supports Using Mindfulness Techniques to Reduce Seizures
Node Smith, ND A study was recently published in the journal Neurology, that supports using mindfulness techniques to reduce seizures in people suffering from epilepsy.1 The lead author, Sheryl R. Haut, MD of montefiore Medical Center and the Albert Einstein College of Medicine in the Bronx, NY, and member of the American Academy of Neurology, […]
Marijuana Derivative Used to Treat Treatment-Resistant Seizures
In a study out of the New York University Langone Medical Center, researchers conducted a year-long study to see the effects of Cannabidiol (CBD), a medical marijuana derivative, was effective in reducing seizure frequency and well-tolerated and safe for most children and young adults. The study was published in Lancet Neurology. In 11 epilepsy centers […]